Oncology Update

Oncology Update

Diane M. Otte

education, Patient education, nursing education
ONF 2012, 39(3), 317-318. DOI: 10.1188/12.ONF.317-318

The U.S. Food and Drug Administration (FDA) has approved oral vismodegib (Erivedge™) for the treatment of adult patients with locally advanced basal cell carcinoma who are not candidates for surgery or radiation and for those with metastatic disease. The drug initially was tested at Scottsdale Healthcare in Arizona.

Jump to a section

    References

    Scottsdale Healthcare. (2012). FDA approves new skin cancer drug first tested in Arizona by Scottsdale Healthcare and TGen [press release]. Retrieved from http://www.prnewswire.com/news-releases/fda-approves-new-skin-cancer-drug-first-tested-in-arizona-by-scottsdale-healthcare-and-tgen-138491769.html
    Joensuu, H., Eriksson, M., Hatrmann, J., Sundby Hall, K., Schutte, J., Reichardt, A., … Reichardt, P. (2011). Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO) [Abstract LBA1]. Retrieved from http://www.asco.org/ascov2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=78836
    Novartis Pharmaceuticals. (2011). Gleevec® (imatinib mesylate) [Prescribing information]. East Hanover, NJ: Author.
    Bang, H. J., Littrup, P. J., Currier, B. P., Goodrich, D. J., & Kassem, M. (2012). Cryoablation of metastatic ovarian cancer for local tumor control: Improved survival and estimated cost effectiveness. Retrieved from http://www.iset.org/oncology/images/stories/Abstracts/abs3.pdf
    International Symposium on Endovascular Therapy. (2012). Tumor-freezing treatment gives ovarian cancer patients extra time [press release]. Retrieved from http://www.isetnews.org/omk.php?pid=1751&sid=S2012040907332124RP7H&pr=1826
    Luddy, J. L. (2012). TherapEase Cuisine™, Medco's cancer nutrition program, expands capabilities to food shipments directly to patients' homes [press release]. Retrieved from http://news.therapeasecuisine.com/pr/te/document/Medco_TherapEaseCuisine_press_release_1_23_12.pdf
    BD Medical. (2012). Study shows nurses are exposed to risks from blood exposure during insertion and removal of peripheral IV catheter [press release]. Retrieved from http://www.bizjournals.com/prnewswire/press_releases/2012/03/07/NY65345
    Jagger, J., Perry, J., Parker, G., & Phillips, E. K. (2011). Nursing 2011 survey results: Blood exposure risk during peripheral IV catheter insertion and removal. Nursing, 41(12), 45-49. doi:10.1097/01.NURSE.0000407678.81635.62
    Onia, R., Eshun-Wilson, I., Arce, C., Ellis, C., Parvu, V., Hassman, D., & Kassler-Taub, K. (2011). Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure. Current Medical Research and Opinion, 27, 1339-1346. doi:10.1185/03007995.2011.581275